原发性胃腺鳞癌：一例报告
Primary Gastric Adenosquamous Carcinoma: A Case Report.
作者信息
Aly Ragia, Gupta Sachin, Gupta Sorab, Nagra Navroop, Goyal Abhinav, Singh Balraj
机构信息
Danbury Hospital, 24 Hospital Ave, Danbury, CT 06810, USA.
Tower Health Reading Hospital, POBox16052, Reading, PA 19612-6052, USA.
出版信息
Gastroenterology Res. 2020 Aug;13(4):155-157. doi: 10.14740/gr1307. Epub 2020 Aug 14.
Abstract
Gastric adenosquamous carcinoma (GASC) is a rare variant of gastric cancer; the limited data available suggest that these tumors are more aggressive and have a worse outcome in comparison to gastric adenocarcinoma. Currently, the management of GASC is similar to adenocarcinoma. We report a case of GASC that progressed rapidly despite treatment.
摘要
胃腺鳞癌（GASC）是胃癌的一种罕见变体；现有的有限数据表明，与胃腺癌相比，这些肿瘤更具侵袭性，预后更差。目前，GASC的治疗方法与腺癌相似。我们报告一例GASC病例，尽管进行了治疗，但病情仍迅速进展。
相似文献
1
Primary Gastric Adenosquamous Carcinoma: A Case Report.原发性胃腺鳞癌：一例报告
Gastroenterology Res. 2020 Aug;13(4):155-157. doi: 10.14740/gr1307. Epub 2020 Aug 14.
2
Gastric squamous cell carcinoma and gastric adenosquamous carcinoma, clinical features and outcomes of rare clinical entities: a National Cancer Database (NCDB) analysis.胃鳞状细胞癌和胃腺鳞癌：罕见临床实体的临床特征与结局——一项国家癌症数据库（NCDB）分析
J Gastrointest Oncol. 2019 Feb;10(1):85-94. doi: 10.21037/jgo.2018.10.06.
3
Clinicopathologic characteristics, survival, and treatments for gastric adenosquamous carcinoma: a population-based study.胃腺鳞癌的临床病理特征、生存和治疗：一项基于人群的研究。
Curr Oncol. 2020 Dec;27(6):e527-e536. doi: 10.3747/co.27.6337. Epub 2020 Dec 1.
4
Case report: Gastric adenosquamous carcinoma with EBV-positive component of squamous cell carcinoma mixed with gastric carcinoma with lymphoid stroma: A novel case report and literature review.病例报告：伴淋巴间质的胃癌中混合有 EBV 阳性的鳞癌成分的胃腺鳞癌：一种新的病例报告及文献复习。
Pathol Oncol Res. 2023 Feb 2;29:1610902. doi: 10.3389/pore.2023.1610902. eCollection 2023.
5
Immunoprofile of adenosquamous carcinoma in gastric cancer.胃腺癌的免疫组化特征。
J Chin Med Assoc. 2023 Jun 1;86(6):542-548. doi: 10.1097/JCMA.0000000000000922. Epub 2023 Mar 29.
6
Primary gastric adenosquamous carcinoma in a Caucasian woman: a case report.一名白种女性的原发性胃腺鳞癌：病例报告。
J Med Case Rep. 2010 Oct 29;4:351. doi: 10.1186/1752-1947-4-351.
7
Cervical Gastric-type Adenosquamous Carcinoma: Case Report of a Rare Neoplasm Associated With a BRCA1 Pathogenic Variant.宫颈胃型腺鳞癌：与 BRCA1 致病性变异相关的罕见肿瘤病例报告。
Int J Gynecol Pathol. 2023 Sep 1;42(5):529-534. doi: 10.1097/PGP.0000000000000946. Epub 2023 Jan 25.
8
A primary gastric Adenosquamous carcinoma: Case report.原发性胃腺鳞癌：病例报告
Int J Surg Case Rep. 2023 May;106:108101. doi: 10.1016/j.ijscr.2023.108101. Epub 2023 Apr 7.
9
[Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].42例原发性胃腺鳞癌患者的临床病理特征及预后分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Feb 25;20(2):207-212.
10
Fatal submucosal invasive gastric adenosquamous carcinoma detected at surveillance after gastric endoscopic submucosal dissection.胃内镜黏膜下剥离术后监测发现的致命性黏膜下浸润性腺鳞癌
World J Gastroenterol. 2015 Apr 14;21(14):4385-90. doi: 10.3748/wjg.v21.i14.4385.
引用本文的文献
1
EZH2 loss promotes gastric squamous cell carcinoma.EZH2缺失促进胃鳞状细胞癌。
Nat Commun. 2025 Jul 1;16(1):6032. doi: 10.1038/s41467-025-61024-5.
本文引用的文献
1
The American Cancer Society's Facts & Figures: 2020 Edition.美国癌症协会《2020年事实与数据》版
J Adv Pract Oncol. 2020 Mar;11(2):135-136. doi: 10.6004/jadpro.2020.11.2.1. Epub 2020 Mar 1.
2
Adenosquamous Carcinoma of the Stomach: A Population-based Study from the SEER Database.胃腺鳞癌：一项基于监测、流行病学和最终结果（SEER）数据库的人群研究
J Cancer. 2019 Sep 7;10(23):5705-5713. doi: 10.7150/jca.29162. eCollection 2019.
3
Gastric squamous cell carcinoma and gastric adenosquamous carcinoma, clinical features and outcomes of rare clinical entities: a National Cancer Database (NCDB) analysis.胃鳞状细胞癌和胃腺鳞癌：罕见临床实体的临床特征与结局——一项国家癌症数据库（NCDB）分析
J Gastrointest Oncol. 2019 Feb;10(1):85-94. doi: 10.21037/jgo.2018.10.06.
4
KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer.KEYNOTE-590：帕博利珠单抗联合或不联合化疗一线治疗晚期食管癌的 III 期研究。
Future Oncol. 2019 Apr;15(10):1057-1066. doi: 10.2217/fon-2018-0609. Epub 2019 Feb 8.
5
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial.帕博利珠单抗对比紫杉醇用于治疗晚期或胃食管结合部腺癌（KEYNOTE-061）：一项随机、开放标签、对照、III 期临床试验。
Lancet. 2018 Jul 14;392(10142):123-133. doi: 10.1016/S0140-6736(18)31257-1. Epub 2018 Jun 4.
6
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial.帕博利珠单抗单药治疗既往治疗的晚期胃和胃食管结合部癌患者的安全性和疗效：Ⅱ期 KEYNOTE-059 临床试验。
JAMA Oncol. 2018 May 10;4(5):e180013. doi: 10.1001/jamaoncol.2018.0013.
7
Clinicopathological features and prognosis of gastric adenosquamous carcinoma.胃腺鳞癌的临床病理特征及预后。
Sci Rep. 2017 Jul 4;7(1):4597. doi: 10.1038/s41598-017-04563-2.
8
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.卡铂和培美曲塞联合或不联合帕博利珠单抗用于晚期非鳞状非小细胞肺癌：开放标签KEYNOTE-021研究的随机2期队列研究
Lancet Oncol. 2016 Nov;17(11):1497-1508. doi: 10.1016/S1470-2045(16)30498-3. Epub 2016 Oct 10.
9
Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial.帕博利珠单抗治疗 PD-L1 阳性晚期胃癌患者（KEYNOTE-012）：一项多中心、开放标签、Ib 期临床试验。
Lancet Oncol. 2016 Jun;17(6):717-726. doi: 10.1016/S1470-2045(16)00175-3. Epub 2016 May 3.
10
Clinicopathological characteristics, diagnosis, treatment, and outcomes of primary gastric adenosquamous carcinoma.原发性胃腺鳞癌的临床病理特征、诊断、治疗及预后
World J Surg Oncol. 2015 Apr 2;13:136. doi: 10.1186/s12957-015-0554-1.
Zotero 插件